| Bioactivity | CDK9-IN-31 dimaleate (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 dimaleate has the potential to be developed as an anticancer agent[1]. |
| Name | CDK9-IN-31 dimaleate |
| Formula | C32H41ClN6O10S |
| Molar Mass | 737.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A. |
CDK9-IN-31 dimaleate
CAS: F: C32H41ClN6O10S W: 737.22
CDK9-IN-31 dimaleate (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 dimaleate has the po
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.